SNG: Saudi: Fakeeh group delivers H1 2025 revenue of $402.4mln, up 13% year-on-year

About this update from Dr. Soliman Abdul Kader Fakeeh Hospital Co.

Staff WriterDr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries (“Fakeeh Care Group”, “FCG”, “Fakeeh Care”, the “Company” or the “Group”), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announced its financial results[1] for the second quarter ended 30 June 2025.Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%.Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah’s double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SR812 million (+24% YoY) and Net Profit after Zakat of SR68 million (+59% YoY); 1H‑2025 revenue was SR1.51 billion (+13% YoY).Commenting on the Group’s performance, FCG’s President Dr. Mazen Soliman Fakeeh said: “In the second quarter of the year, Fakeeh Care Group revenues reached to SR812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah’s year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh’s disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SR154 million in the first half (SR82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities —investments that are underpinning our multi‑year growth trajectory.In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) ...

View stock analysis, news, and events for Dr. Soliman Abdul Kader Fakeeh Hospital Co.